Chemotherapy patch being developed; FDA grants IDE to TherOx's cardiology device;

> Caltech student Teo Wilkening and professors are developing a patch for the painless delivery of chemotherapy. More

> Irvine, CA's TherOx announced it received an Investigational Device Exemption (IDE) from the FDA to conduct a safety study of its Supersaturated Oxygen Therapy, which is intended to reduce the size of lesions that form as a result of tissue death following a heart attack. The 100-person study will support the device's PMA application. More

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.